Hope Jason 13D/13G Filings for Outlook Therapeutics, Inc. (OTLK)

Hope Jason 13D and 13G filings for Outlook Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-17
8:14 pm
Purchase
2022-12-31 13G Outlook Therapeutics, Inc.
OTLK
Hope Jason 1,000,000
7.800%
249,382increase
(+33.22%)
Filing
2022-04-01
4:31 pm
Purchase
2022-03-18 13G Outlook Therapeutics, Inc.
OTLK
Hope Jason 750,618
6.690%
750,618increase
(New Position)
Filing